Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) (Q83112096)
Jump to navigation
Jump to search
scientific article published on 01 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) |
scientific article published on 01 January 2012 |
Statements
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) (English)
Josep Redon
Giuseppe Mancia
Peter Sleight
Helmut Schumacher
Peggy Gao
Janice Pogue
Robert Fagard
Paolo Verdecchia
Michael Weber
Michael Böhm
Bryan Williams
Khalid Yusoff
Salim Yusuf
ONTARGET Investigators